Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy. [electronic resource]
Producer: 20180221ISSN:- 1758-2652
- Anti-HIV Agents -- therapeutic use
- CD4 Lymphocyte Count
- Child
- Child, Preschool
- Female
- HIV -- classification
- HIV Infections -- complications
- Humans
- Leukocytes, Mononuclear
- Lopinavir -- therapeutic use
- Male
- Neurocognitive Disorders -- etiology
- Reverse Transcriptase Inhibitors -- therapeutic use
- Uganda
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.